Peroxisomal ABC transporters: Structure, function and role in disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 9, 2012, Pages 1387-1396

  Morita, Masashi ^a   Imanaka, Tsuneo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

ABC transporter; Acyl CoA transport; Adrenoleukodystrophy; Fatty acid oxidation; Peroxisome targeting

Indexed keywords

ABC TRANSPORTER; ABCD1 PROTEIN; ABCD2 PROTEIN; ABCD3 PROTEIN; DOCOSAHEXAENOIC ACID; FATTY ACID; MYELIN; PEROXIN 19; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POLYUNSATURATED FATTY ACID; RETINOID X RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; THYROID HORMONE RECEPTOR; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ARABIDOPSIS; ASTROCYTE; BINDING SITE; CAENORHABDITIS ELEGANS; CELL DIVISION; CELL GROWTH; CELLULAR DISTRIBUTION; CYTOSOL; DEGENERATIVE DISEASE; DICTYOSTELIUM DISCOIDEUM; DIMERIZATION; DISEASE COURSE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GENE EXPRESSION; GENE MUTATION; GLIA; HUMAN; HYDROLYSIS; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MICROGLIA; MOLECULAR DOCKING; NERVE FIBER; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PATHOGENESIS; PEROXISOME; PHENOTYPE; PODOSPORA ANSERINA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN STRUCTURE; PROTEIN TARGETING; PROTEIN TRANSPORT; REVIEW; SACCHAROMYCES CEREVISIAE; TRYPANOSOMA BRUCEI;

ACYL COENZYME A; ADRENOLEUKODYSTROPHY; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT, ACTIVE; HUMANS; LIPID METABOLISM; NEURONS; PEROXISOMES; PHYLOGENY; PROTEIN CONFORMATION; PROTEIN TRANSPORT;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 84864052256     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.02.009     Document Type: Review

References (113)

1. Wanders R.J., Waterham H.R. Biochemistry of mammalian peroxisomes revisited. Annu. Rev. Biochem. 2006, 75:295-332.
2. Van Veldhoven P.P. Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J. Lipid Res. 2010, 51:2863-2895.
3. Islinger M., Cardoso M.J., Schrader M. Be different-the diversity of peroxisomes in the animal kingdom. Biochim. Biophys. Acta 2010, 1803:881-897.
4. Visser W.F., van Roermund C.W., Ijlst L., Waterham H.R., Wanders R.J. Metabolite transport across the peroxisomal membrane. Biochem. J. 2007, 401:365-375.
5. Higgins C.F. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 1992, 8:67-113.
6. Saurin W., Hofnung M., Dassa E. Getting in or out: early segregation between importers and exporters in the evolution of ATP-binding cassette (ABC) transporters. J. Mol. Evol. 1999, 48:22-41.
7. Dassa E., Bouige P. The ABC of ABCS: a phylogenetic and functional classification of ABC systems in living organisms. Res. Microbiol. 2001, 152:211-229.
8. Vasiliou V., Vasiliou K., Nebert D.W. Human ATP-binding cassette (ABC) transporter family. Hum. Genomics 2009, 3:281-290.
9. Mosser J., Douar A.M., Sarde C.O., Kioschis P., Feil R., Moser H., Poustka A.M., Mandel J.L., Aubourg P. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993, 361:726-730.
10. Lombard-Platet G., Savary S., Sarde C.O., Mandel J.L., Chimini G. A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:1265-1269.
11. Holzinger A., Kammerer S., Berger J., Roscher A.A. cDNA cloning and mRNA expression of the human adrenoleukodystrophy related protein (ALDRP), a peroxisomal ABC transporter. Biochem. Biophys. Res. Commun. 1997, 239:261-264.
12. Gartner J., Moser H., Valle D. Mutations in the 70K peroxisomal membrane protein gene in Zellweger syndrome. Nat. Genet. 1992, 1:16-23.
13. Kamijo K., Kamijo T., Ueno I., Osumi T., Hashimoto T. Nucleotide sequence of the human 70kDa peroxisomal membrane protein: a member of ATP-binding cassette transporters. Biochim. Biophys. Acta 1992, 1129:323-327.
14. Kamijo K., Taketani S., Yokota S., Osumi T., Hashimoto T. The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily. J. Biol. Chem. 1990, 265:4534-4540.
15. Netik A., Forss-Petter S., Holzinger A., Molzer B., Unterrainer G., Berger J. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy. Hum. Mol. Genet. 1999, 8:907-913.
16. Imanaka T., Aihara K., Takano T., Yamashita A., Sato R., Suzuki Y., Yokota S., Osumi T. Characterization of the 70-kDa peroxisomal membrane protein, an ATP binding cassette transporter. J. Biol. Chem. 1999, 274:11968-11976.
17. Holzinger A., Kammerer S., Roscher A.A. Primary structure of human PMP69, a putative peroxisomal ABC-transporter. Biochem. Biophys. Res. Commun. 1997, 237:152-157.
18. Shani N., Jimenez-Sanchez G., Steel G., Dean M., Valle D. Identification of a fourth half ABC transporter in the human peroxisomal membrane. Hum. Mol. Genet. 1997, 6:1925-1931.
19. 2-terminal hydrophobic property determines the subcellular localization of ABC subfamily D proteins. Exp. Cell Res. 2009, 315:190-205.
20. Kemp S., Theodoulou F.L., Wanders R.J. Mammalian peroxisomal ABC transporters: from endogenous substrates to pathology and clinical significance. Br. J. Pharmacol. 2011, 164:1753-1766.
21. Contreras M., Sengupta T.K., Sheikh F., Aubourg P., Singh I. Topology of ATP-binding domain of adrenoleukodystrophy gene product in peroxisomes. Arch. Biochem. Biophys. 1996, 334:369-379.
22. Roerig P., Mayerhofer P., Holzinger A., Gartner J. Characterization and functional analysis of the nucleotide binding fold in human peroxisomal ATP binding cassette transporters. FEBS Lett. 2001, 492:66-72.
23. Tanaka A.R., Tanabe K., Morita M., Kurisu M., Kasiwayama Y., Matsuo M., Kioka N., Amachi T., Imanaka T., Ueda K. ATP binding/hydrolysis by and phosphorylation of peroxisomal ATP-binding cassette proteins PMP70 (ABCD3) and adrenoleukodystrophy protein (ABCD1). J. Biol. Chem. 2002, 277:40142-40147.
24. Kashiwayama Y., Morita M., Kamijo K., Imanaka T. Nucleotide-induced conformational changes of PMP70, an ATP binding cassette transporter on rat liver peroxisomal membranes. Biochem. Biophys. Res. Commun. 2002, 291:1245-1251.
25. Guimaraes C.P., Sa-Miranda C., Azevedo J.E. Probing substrate-induced conformational alterations in adrenoleukodystrophy protein by proteolysis. J. Hum. Genet. 2005, 50:99-105.
26. Liu L.X., Janvier K., Berteaux-Lecellier V., Cartier N., Benarous R., Aubourg P. Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters. J. Biol. Chem. 1999, 274:32738-32743.
27. Guimaraes C.P., Domingues P., Aubourg P., Fouquet F., Pujol A., Jimenez-Sanchez G., Sa-Miranda C., Azevedo J.E. Mouse liver PMP70 and ALDP: homomeric interactions prevail in vivo. Biochim. Biophys. Acta 2004, 1689:235-243.
28. Hillebrand M., Verrier S.E., Ohlenbusch A., Schafer A., Soling H.D., Wouters F.S., Gartner J. Live cell FRET microscopy: homo- and heterodimerization of two human peroxisomal ABC transporters, the adrenoleukodystrophy protein (ALDP, ABCD1) and PMP70 (ABCD3). J. Biol. Chem. 2007, 282:26997-27005.
29. Aller S.G., Yu J., Ward A., Weng Y., Chittaboina S., Zhuo R., Harrell P.M., Trinh Y.T., Zhang Q., Urbatsch I.L., Chang G. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 2009, 323:1718-1722.
30. Dawson R.J., Locher K.P. Structure of a bacterial multidrug ABC transporter. Nature 2006, 443:180-185.
31. Ward A., Reyes C.L., Yu J., Roth C.B., Chang G. Flexibility in the ABC transporter MsbA: alternating access with a twist. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19005-19010.
32. Kim P.K., Mullen R.T., Schumann U., Lippincott-Schwartz J. The origin and maintenance of mammalian peroxisomes involves a de novo PEX16-dependent pathway from the ER. J. Cell Biol. 2006, 173:521-532.
33. Matsuzaki T., Fujiki Y. The peroxisomal membrane protein import receptor Pex3p is directly transported to peroxisomes by a novel Pex19p- and Pex16p-dependent pathway. J. Cell Biol. 2008, 183:1275-1286.
34. Rucktaschel R., Girzalsky W., Erdmann R. Protein import machineries of peroxisomes. Biochim. Biophys. Acta 2011, 1808:892-900.
35. van der Zand A., Braakman I., Tabak H.F. Peroxisomal membrane proteins insert into the endoplasmic reticulum. Mol. Biol. Cell 2010, 21:2057-2065.
36. Ma C., Agrawal G., Subramani S. Peroxisome assembly: matrix and membrane protein biogenesis. J. Cell Biol. 2011, 193:7-16.
37. Fujiki Y., Matsuzono Y., Matsuzaki T., Fransen M. Import of peroxisomal membrane proteins: the interplay of Pex3p- and Pex19p-mediated interactions. Biochim. Biophys. Acta 2006, 1763:1639-1646.
38. Shibata H., Kashiwayama Y., Imanaka T., Kato H. Domain architecture and activity of human Pex19p, a chaperone-like protein for intracellular trafficking of peroxisomal membrane proteins. J. Biol. Chem. 2004, 279:38486-38494.
39. Kashiwayama Y., Asahina K., Shibata H., Morita M., Muntau A.C., Roscher A.A., Wanders R.J., Shimozawa N., Sakaguchi M., Kato H., Imanaka T. Role of Pex19p in the targeting of PMP70 to peroxisome. Biochim. Biophys. Acta 2005, 1746:116-128.
40. Sato Y., Shibata H., Nakatsu T., Nakano H., Kashiwayama Y., Imanaka T., Kato H. Structural basis for docking of peroxisomal membrane protein carrier Pex19p onto its receptor Pex3p. EMBO J. 2010, 29:4083-4093.
41. Schmidt F., Treiber N., Zocher G., Bjelic S., Steinmetz M.O., Kalbacher H., Stehle T., Dodt G. Insights into peroxisome function from the structure of PEX3 in complex with a soluble fragment of PEX19. J. Biol. Chem. 2010, 285:25410-25417.
42. Biermanns M., Gartner J. Targeting elements in the amino-terminal part direct the human 70-kDa peroxisomal integral membrane protein (PMP70) to peroxisomes. Biochem. Biophys. Res. Commun. 2001, 285:649-655.
43. Kashiwayama Y., Asahina K., Morita M., Imanaka T. Hydrophobic regions adjacent to transmembrane domains 1 and 5 are important for the targeting of the 70-kDa peroxisomal membrane protein. J. Biol. Chem. 2007, 282:33831-33844.
44. Sacksteder K.A., Jones J.M., South S.T., Li X., Liu Y., Gould S.J. PEX19 binds multiple peroxisomal membrane proteins, is predominantly cytoplasmic, and is required for peroxisome membrane synthesis. J. Cell Biol. 2000, 148:931-944.
45. Rottensteiner H., Kramer A., Lorenzen S., Stein K., Landgraf C., Volkmer-Engert R., Erdmann R. Peroxisomal membrane proteins contain common Pex19p-binding sites that are an integral part of their targeting signals. Mol. Biol. Cell 2004, 15:3406-3417.
46. Halbach A., Lorenzen S., Landgraf C., Volkmer-Engert R., Erdmann R., Rottensteiner H. Function of the PEX19-binding site of human adrenoleukodystrophy protein as targeting motif in man and yeast. PMP targeting is evolutionarily conserved. J. Biol. Chem. 2005, 280:21176-21182.
47. Cartier N., Lopez J., Moullier P., Rocchiccioli F., Rolland M.O., Jorge P., Mosser J., Mandel J.L., Bougneres P.F., Danos O., Aubourg P. Retroviral-mediated gene transfer corrects very-long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:1674-1678.
48. Braiterman L.T., Zheng S., Watkins P.A., Geraghty M.T., Johnson G., McGuinness M.C., Moser A.B., Smith K.D. Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins. Hum. Mol. Genet. 1998, 7:239-247.
49. van Roermund C.W., Visser W.F., Ijlst L., van Cruchten A., Boek M., Kulik W., Waterham H.R., Wanders R.J. The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters. FASEB J. 2008, 22:4201-4208.
50. van Roermund C.W., Visser W.F., Ijlst L., Waterham H.R., Wanders R.J. Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid β-oxidation. Biochim. Biophys. Acta 2011, 1811:148-152.
51. Ofman R., Dijkstra I.M., van Roermund C.W., Burger N., Turkenburg M., van Cruchten A., van Engen C.E., Wanders R.J., Kemp S. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. EMBO Mol. Med. 2011, 2:90-97.
52. Weinhofer I., Forss-Petter S., Zigman M., Berger J. Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy. Hum. Mol. Genet. 2002, 11:2701-2708.
53. Weinhofer I., Forss-Petter S., Kunze M., Zigman M., Berger J. X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism. FEBS Lett. 2005, 579:5512-5516.
54. Pujol A., Ferrer I., Camps C., Metzger E., Hindelang C., Callizot N., Ruiz M., Pampols T., Giros M., Mandel J.L. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum. Mol. Genet. 2004, 13:2997-3006.
55. Zhang X., De Marcos Lousa C., Schutte-Lensink N., Ofman R., Wanders R.J., Baldwin S.A., Baker A., Kemp S., Theodoulou F.L. Conservation of targeting but divergence in function and quality control of peroxisomal ABC transporters: an analysis using cross-kingdom expression. Biochem. J. 2011, 436:547-557.
56. Fourcade S., Ruiz M., Camps C., Schluter A., Houten S.M., Mooyer P.A., Pampols T., Dacremont G., Wanders R.J., Giros M., Pujol A. A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E211-E221.
57. Genin E.C., Geillon F., Gondcaille C., Athias A., Gambert P., Trompier D., Savary S. Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2). J. Biol. Chem. 2011, 286:8075-8084.
58. Fourcade S., Ruiz M., Guilera C., Hahnen E., Brichta L., Naudi A., Portero-Otin M., Dacremont G., Cartier N., Wanders R., Kemp S., Mandel J.L., Wirth B., Pamplona R., Aubourg P., Pujol A. Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy. Hum. Mol. Genet. 2010, 19:2005-2014.
59. Lu J.F., Barron-Casella E., Deering R., Heinzer A.K., Moser A.B., deMesy Bentley K.L., Wand G.S., C.M.M, Pei Z., Watkins P.A., Pujol A., Smith K.D., Powers J.M. The role of peroxisomal ABC transporters in the mouse adrenal gland: the loss of Abcd2 (ALDR), not Abcd1 (ALD), causes oxidative damage. Lab. Invest. 2007, 87:261-272.
60. Weinhofer I., Kunze M., Rampler H., Forss-Petter S., Samarut J., Plateroti M., Berger J. Distinct modulatory roles for thyroid hormone receptors TRα and TRβ in SREBP1-activated ABCD2 expression. Eur. J. Cell Biol. 2008, 87:933-945.
61. Weinhofer I., Kunze M., Rampler H., Bookout A.L., Forss-Petter S., Berger J. Liver X receptor α interferes with SREBP1c-mediated Abcd2 expression. Novel cross-talk in gene regulation. J. Biol. Chem. 2005, 280:41243-41251.
62. Hoftberger R., Kunze M., Weinhofer I., Aboul-Enein F., Voigtlander T., Oezen I., Amann G., Bernheimer H., Budka H., Berger J. Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy. Neurobiol. Dis. 2007, 28:165-174.
63. Troffer-Charlier N., Doerflinger N., Metzger E., Fouquet F., Mandel J.L., Aubourg P. Mirror expression of adrenoleukodystrophy and adrenoleukodystrophy related genes in mouse tissues and human cell lines. Eur. J. Cell Biol. 1998, 75:254-264.
64. Bezman L., Moser A.B., Raymond G.V., Rinaldo P., Watkins P.A., Smith K.D., Kass N.E., Moser H.W. Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann. Neurol. 2001, 49:512-517.
65. Moser H.W. Therapy of X-linked adrenoleukodystrophy. NeuroRx 2006, 3:246-253.
66. Kemp S., Wanders R. Biochemical aspects of X-linked adrenoleukodystrophy. Brain Pathol. 2010, 20:831-837.
67. Morita M., Shimozawa N., Kashiwayama Y., Suzuki Y., Imanaka T. ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy. Curr. Drug Targets 2011, 12:694-706.
68. Asheuer M., Bieche I., Laurendeau I., Moser A., Hainque B., Vidaud M., Aubourg P. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy. Hum. Mol. Genet. 2005, 14:1293-1303.
69. Jang J., Kang H.C., Kim H.S., Kim J.Y., Huh Y.J., Kim D.S., Yoo J.E., Lee J.A., Lim B., Lee J., Yoon T.M., Park I.H., Hwang D.Y., Daley G.Q., Kim D.W. Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients. Ann. Neurol. 2011, 402-409.
70. Moser H.W. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 1997, 120(Pt. 8):1485-1508.
71. Khan M., Singh J., Gilg A.G., Uto T., Singh I. Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy. J. Lipid Res. 2010, 51:1685-1695.
72. Hein S., Schonfeld P., Kahlert S., Reiser G. Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hum. Mol. Genet. 2008, 17:1750-1761.
73. Di Biase A., Avellino C., Pieroni F., Quaresima T., Grisolia A., Cappa M., Salvati S. Effects of exogenous hexacosanoic acid on biochemical myelin composition in weaning and post-weaning rats. Neurochem. Res. 1997, 22:327-331.
74. Ito M., Blumberg B.M., Mock D.J., Goodman A.D., Moser A.B., Moser H.W., Smith K.D., Powers J.M. Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J. Neuropathol. Exp. Neurol. 2001, 60:1004-1019.
75. Powers J.M., Pei Z., Heinzer A.K., Deering R., Moser A.B., Moser H.W., Watkins P.A., Smith K.D. Adreno-leukodystrophy: oxidative stress of mice and men. J. Neuropathol. Exp. Neurol. 2005, 64:1067-1079.
76. Fourcade S., Lopez-Erauskin J., Galino J., Duval C., Naudi A., Jove M., Kemp S., Villarroya F., Ferrer I., Pamplona R., Portero-Otin M., Pujol A. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum. Mol. Genet. 2008, 17:1762-1773.
77. Galino J., Ruiz M., Fourcade S., Schluter A., Lopez-Erauskin J., Guilera C., Jove M., Naudi A., Garcia-Arumi E., Andreu A.L., Starkov A.A., Pamplona R., Ferrer I., Portero-Otin M., Pujol A. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy. Antioxid. Redox Signal. 2011, 15:2095-2107.
78. Lopez-Erauskin J., Fourcade S., Galino J., Ruiz M., Schluter A., Naudi A., Jove M., Portero-Otin M., Pamplona R., Ferrer I., Pujol A. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. Ann. Neurol. 2011, 70:84-92.
79. Brites P., Mooyer P.A., El Mrabet L., Waterham H.R., Wanders R.J. Plasmalogens participate in very-long-chain fatty acid-induced pathology. Brain 2009, 132:482-492.
80. Khan M., Singh J., Singh I. Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin. J. Neurochem. 2008, 106:1766-1779.
81. Matsukawa T., Asheuer M., Takahashi Y., Goto J., Suzuki Y., Shimozawa N., Takano H., Onodera O., Nishizawa M., Aubourg P., Tsuji S. Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes. Neurogenetics 2011, 12:41-50.
82. Maier E.M., Mayerhofer P.U., Asheuer M., Kohler W., Rothe M., Muntau A.C., Roscher A.A., Holzinger A., Aubourg P., Berger J. X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype. Biochem. Biophys. Res. Commun. 2008, 377:176-180.
83. Raymond G.V., Seidman R., Monteith T.S., Kolodny E., Sathe S., Mahmood A., Powers J.M. Head trauma can initiate the onset of adreno-leukodystrophy. J. Neurol. Sci. 2010, 290:70-74.
84. Bottelbergs A., Verheijden S., Hulshagen L., Gutmann D.H., Goebbels S., Nave K.A., Kassmann C., Baes M. Axonal integrity in the absence of functional peroxisomes from projection neurons and astrocytes. Glia 2010, 58:1532-1543.
85. Kassmann C.M., Lappe-Siefke C., Baes M., Brugger B., Mildner A., Werner H.B., Natt O., Michaelis T., Prinz M., Frahm J., Nave K.A. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat. Genet. 2007, 39:969-976.
86. Kassmann C.M., Nave K.A. Oligodendroglial impact on axonal function and survival - a hypothesis. Curr. Opin. Neurol. 2008, 21:235-241.
87. Baes M., Aubourg P. Peroxisomes, myelination, and axonal integrity in the CNS. Neuroscientist 2009, 15:367-379.
88. Nash B., Ioannidou K., Barnett S.C. Astrocyte phenotypes and their relationship to myelination. J. Anat. 2010, 219:44-52.
89. Pfrieger F.W., Ungerer N. Cholesterol metabolism in neurons and astrocytes. Prog. Lipid Res. 2011, 50:357-371.
90. Hayashi H., Campenot R.B., Vance D.E., Vance J.E. Glial lipoproteins stimulate axon growth of central nervous system neurons in compartmented cultures. J. Biol. Chem. 2004, 279:14009-14015.
91. Cartier N., Hacein-Bey-Abina S., Bartholomae C.C., Veres G., Schmidt M., Kutschera I., Vidaud M., Abel U., Dal-Cortivo L., Caccavelli L., Mahlaoui N., Kiermer V., Mittelstaedt D., Bellesme C., Lahlou N., Lefrere F., Blanche S., Audit M., Payen E., Leboulch P., l'Homme B., Bougneres P., Von Kalle C., Fischer A., Cavazzana-Calvo M., Aubourg P. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009, 326:818-823.
92. Yamada T., Ohyagi Y., Shinnoh N., Kikuchi H., Osoegawa M., Ochi H., Kira J., Furuya H. Therapeutic effects of normal cells on ABCD1 deficient cells in vitro and hematopoietic cell transplantation in the X-ALD mouse model. J. Neurol. Sci. 2004, 218:91-97.
93. Eichler F.S., Ren J.Q., Cossoy M., Rietsch A.M., Nagpal S., Moser A.B., Frosch M.P., Ransohoff R.M. Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?. Ann. Neurol. 2008, 63:729-742.
94. Hayashi M., Nito K., Takei-Hoshi R., Yagi M., Kondo M., Suenaga A., Yamaya T., Nishimura M. Ped3p is a peroxisomal ATP-binding cassette transporter that might supply substrates for fatty acid β-oxidation. Plant Cell Physiol. 2002, 43:1-11.
95. Footitt S., Slocombe S.P., Larner V., Kurup S., Wu Y., Larson T., Graham I., Baker A., Holdsworth M. Control of germination and lipid mobilization by COMATOSE, the Arabidopsis homologue of human ALDP. EMBO J. 2002, 21:2912-2922.
96. Zolman B.K., Silva I.D., Bartel B. The Arabidopsis pxa1 mutant is defective in an ATP-binding cassette transporter-like protein required for peroxisomal fatty acid β-oxidation. Plant Physiol. 2001, 127:1266-1278.
97. Kunz H.H., Scharnewski M., Feussner K., Feussner I., Flugge U.I., Fulda M., Gierth M. The ABC transporter PXA1 and peroxisomal β-oxidation are vital for metabolism in mature leaves of Arabidopsis during extended darkness. Plant Cell 2009, 21:2733-2749.
98. Nyathi Y., De Marcos Lousa C., van Roermund C.W., Wanders R.J., Johnson B., Baldwin S.A., Theodoulou F.L., Baker A. The Arabidopsis peroxisomal ABC transporter, comatose, complements the Saccharomyces cerevisiae pxa1pxa2Delta mutant for metabolism of long-chain fatty acids and exhibits fatty acyl-CoA-stimulated ATPase activity. J. Biol. Chem. 2010, 285:29892-29902.
99. Theodoulou F.L., Job K., Slocombe S.P., Footitt S., Holdsworth M., Baker A., Larson T.R., Graham I.A. Jasmonic acid levels are reduced in COMATOSE ATP-binding cassette transporter mutants. Implications for transport of jasmonate precursors into peroxisomes. Plant Physiol. 2005, 137:835-840.
100. Theodoulou F.L., Holdsworth M., Baker A. Peroxisomal ABC transporters. FEBS Lett. 2006, 580:1139-1155.
101. Sanchez-Fernandez R., Davies T.G., Coleman J.O., Rea P.A. The Arabidopsis thaliana ABC protein superfamily, a complete inventory. J. Biol. Chem. 2001, 276:30231-30244.
102. Yernaux C., Fransen M., Brees C., Lorenzen S., Michels P.A. Trypanosoma brucei glycosomal ABC transporters: identification and membrane targeting. Mol. Membr. Biol. 2006, 23:157-172.
103. Igoillo-Esteve M., Mazet M., Deumer G., Wallemacq P., Michels P.A. Glycosomal ABC transporters of Trypanosoma brucei: characterisation of their expression, topology and substrate specificity. Int. J. Parasitol. 2011, 41:429-438.
104. Petriv O.I., Pilgrim D.B., Rachubinski R.A., Titorenko V.I. RNA interference of peroxisome-related genes in C. elegans: a new model for human peroxisomal disorders. Physiol. Genomics 2002, 10:79-91.
105. Joo H.J., Yim Y.H., Jeong P.Y., Jin Y.X., Lee J.E., Kim H., Jeong S.K., Chitwood D.J., Paik Y.K. Caenorhabditis elegans utilizes dauer pheromone biosynthesis to dispose of toxic peroxisomal fatty acids for cellular homoeostasis. Biochem. J. 2009, 422:61-71.
106. Hettema E.H., van Roermund C.W., Distel B., van den Berg M., Vilela C., Rodrigues-Pousada C., Wanders R.J., Tabak H.F. The ABC transporter proteins Pat1 and Pat2 are required for import of long-chain fatty acids into peroxisomes of Saccharomyces cerevisiae. EMBO J. 1996, 15:3813-3822.
107. Verleur N., Hettema E.H., van Roermund C.W., Tabak H.F., Wanders R.J. Transport of activated fatty acids by the peroxisomal ATP-binding-cassette transporter Pxa2 in a semi-intact yeast cell system. Eur. J. Biochem. 1997, 249:657-661.
108. Matsuoka S., Kuwayama H., Ikeno D., Oyama M., Maeda M. Defect in peroxisomal multifunctional enzyme MFE1 affects cAMP relay in Dictyostelium. Dev. Growth Differ. 2004, 46:195-199.
109. Matsuoka S., Saito T., Kuwayama H., Morita N., Ochiai H., Maeda M. MFE1, a member of the peroxisomal hydroxyacyl coenzyme A dehydrogenase family, affects fatty acid metabolism necessary for morphogenesis in Dictyostelium spp. Eukaryot. Cell 2003, 2:638-645.
110. Anjard C., Loomis W.F. Evolutionary analyses of ABC transporters of Dictyostelium discoideum. Eukaryot. Cell 2002, 1:643-652.
111. Boisnard S., Espagne E., Zickler D., Bourdais A., Riquet A.L., Berteaux-Lecellier V. Peroxisomal ABC transporters and β-oxidation during the life cycle of the filamentous fungus Podospora anserina. Fungal Genet. Biol. 2009, 46:55-66.
112. Ho J.K., Moser H., Kishimoto Y., Hamilton J.A. Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy. J. Clin. Invest. 1995, 96:1455-1463.
113. McNicholas S., Potterton E., Wilson K.S., Noble M.E. Presenting your structures: the CCP4mg molecular-graphics software. Acta Crystallogr. D Biol. Crystallogr. 2011, 67:386-394.